Key Points
- DocuSign CFO Blake Jeffrey Grayson sold 9,515 shares on December 17 at an average price of $68.33 for about $650,160, reducing his position by 7.45% to 118,213 shares (worth roughly $8.08M).
- He previously sold 6,500 shares on October 1 at $71.20, indicating multiple insider sales this year.
- DocuSign has a market cap of $13.64B and a one‑year range of $63.41–$99.30, with a MarketBeat consensus rating of "Hold" and an average target price of $86.80.
Docusign Inc. (NASDAQ:DOCU - Get Free Report) insider Robert Chatwani sold 1,683 shares of the business's stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $70.87, for a total transaction of $119,274.21. Following the completion of the transaction, the insider owned 68,496 shares in the company, valued at $4,854,311.52. The trade was a 2.40% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Robert Chatwani also recently made the following trade(s):
- On Wednesday, December 17th, Robert Chatwani sold 13,818 shares of Docusign stock. The stock was sold at an average price of $68.33, for a total transaction of $944,183.94.
- On Thursday, December 11th, Robert Chatwani sold 983 shares of Docusign stock. The shares were sold at an average price of $68.62, for a total transaction of $67,453.46.
Docusign Trading Up 0.3%
Docusign stock traded up $0.17 during mid-day trading on Thursday, hitting $67.96. The company's stock had a trading volume of 415,163 shares, compared to its average volume of 2,749,383. The firm has a market capitalization of $13.61 billion, a PE ratio of 47.24, a price-to-earnings-growth ratio of 3.39 and a beta of 0.98. Docusign Inc. has a 1 year low of $63.41 and a 1 year high of $99.30. The stock's fifty day moving average is $68.97 and its two-hundred day moving average is $74.21.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on DOCU. Needham & Company LLC reiterated a "hold" rating on shares of Docusign in a report on Wednesday. BTIG Research initiated coverage on shares of Docusign in a research report on Tuesday. They issued a "buy" rating and a $88.00 target price on the stock. Citigroup lifted their price target on shares of Docusign from $110.00 to $115.00 and gave the company a "buy" rating in a research report on Thursday, September 4th. Robert W. Baird decreased their price objective on shares of Docusign from $90.00 to $75.00 and set a "neutral" rating on the stock in a report on Friday, December 5th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Docusign from $80.00 to $78.00 and set a "neutral" rating for the company in a research report on Friday, December 5th. Six investment analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company's stock. According to MarketBeat, Docusign currently has an average rating of "Hold" and a consensus price target of $86.80.
Read Our Latest Report on Docusign
Institutional Trading of Docusign
Several hedge funds have recently made changes to their positions in the business. HighTower Advisors LLC grew its holdings in shares of Docusign by 15.2% in the first quarter. HighTower Advisors LLC now owns 45,690 shares of the company's stock valued at $3,719,000 after purchasing an additional 6,013 shares in the last quarter. Aberdeen Group plc boosted its position in Docusign by 130.0% in the 1st quarter. Aberdeen Group plc now owns 108,969 shares of the company's stock valued at $8,870,000 after buying an additional 61,598 shares during the period. Ethic Inc. grew its stake in shares of Docusign by 281.8% in the first quarter. Ethic Inc. now owns 14,485 shares of the company's stock worth $1,198,000 after acquiring an additional 10,691 shares in the last quarter. Raymond James Financial Inc. increased its position in shares of Docusign by 5.1% during the first quarter. Raymond James Financial Inc. now owns 449,139 shares of the company's stock worth $36,560,000 after acquiring an additional 21,640 shares during the period. Finally, Corient IA LLC acquired a new stake in shares of Docusign in the first quarter valued at $204,000. Institutional investors and hedge funds own 77.64% of the company's stock.
About Docusign
(
Get Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
